Cargando…
BNT162b2 Protection against the Omicron Variant in Children and Adolescents
BACKGROUND: Spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 (omicron) variant, which led to increased U.S. hospitalizations for coronavirus disease 2019 (Covid-19), generated concern about immune evasion and the duration of protection from vaccines in children an...
Ejemplares similares
-
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants
por: Halasa, Natasha B., et al.
Publicado: (2022) -
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents
por: Olson, Samantha M., et al.
Publicado: (2022) -
Risk factors for health impairments in children after hospitalization for acute COVID-19 or MIS-C
por: Maddux, Aline B., et al.
Publicado: (2023) -
NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2–related complications
por: Bodansky, Aaron, et al.
Publicado: (2023) -
Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak
por: Halasa, Natasha, et al.
Publicado: (2023)